KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares RepurchasedShort-Term Debt repayments
Ratios

Johnson & Johnson (JNJ) EBIAT (2016 - 2025)

Johnson & Johnson's EBIAT history spans 17 years, with the latest figure at $5.1 billion for Q4 2025.

  • For Q4 2025, EBIAT rose 49.11% year-over-year to $5.1 billion; the TTM value through Dec 2025 reached $26.8 billion, up 90.56%, while the annual FY2025 figure was $26.8 billion, 90.56% up from the prior year.
  • EBIAT for Q4 2025 was $5.1 billion at Johnson & Johnson, down from $5.2 billion in the prior quarter.
  • Across five years, EBIAT topped out at $26.0 billion in Q4 2023 and bottomed at -$491.0 million in Q2 2023.
  • The 5-year median for EBIAT is $4.6 billion (2022), against an average of $5.4 billion.
  • The largest YoY upside for EBIAT was 1712.28% in 2023 against a maximum downside of 110.74% in 2023.
  • A 5-year view of EBIAT shows it stood at $3.7 billion in 2021, then grew by 17.53% to $4.3 billion in 2022, then decreased by 4.13% to $4.1 billion in 2023, then fell by 16.97% to $3.4 billion in 2024, then surged by 49.11% to $5.1 billion in 2025.
  • Per Business Quant, the three most recent readings for JNJ's EBIAT are $5.1 billion (Q4 2025), $5.2 billion (Q3 2025), and $5.5 billion (Q2 2025).